March 10, 2025
Recent research indicates that GLP-1 drugs like Ozempic, initially approved for diabetes and weight loss, may offer additional health benefits. These include potential protective effects against age-related conditions such as Alzheimer’s disease, osteoarthritis, certain cancers, and overall mortality.
To read full article, visit: Ozempic’s New Frontier: The War on Aging – WSJ